NovaBay Pharmaceuticals
23 hedge funds and large institutions have $432K invested in NovaBay Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$51.9K | |
| 2 | +$10.4K | |
| 3 | +$9K | |
| 4 |
SG
StoneX Group
New York
|
+$3.72K |
| 5 |
Millennium Management
New York
|
+$3K |
Top Sellers
| 1 | -$36.9K | |
| 2 | -$3K | |
| 3 | -$3K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$600 |